
|Articles|August 11, 2008
FDA is warning that patients should receive genetic testing before obtaining Ziagen
FDA warns about AIDS drug, abacavir, due to increased risk of potentially fatal side effects for some patients.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
The Prodigious PBM Pivot: How Supply Chain Entities Will Move Forward After CAA 2026
2
Executive Order Calls for Realignment of Childhood Vaccines
3
Q&A: Pharmacists Can Address ADA Standards Across All Settings
4
Embedded Pharmacists Are Vital Yet Underutilized in Diabetes Care
5





























































